BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 8545530)

  • 1. Reversal of triazolam- and zolpidem-induced memory impairment by flumazenil.
    Wesensten NJ; Balkin TJ; Davis HQ; Belenky GL
    Psychopharmacology (Berl); 1995 Sep; 121(2):242-9. PubMed ID: 8545530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retrograde effects of triazolam and zolpidem on sleep-dependent motor learning in humans.
    Morgan PT; Kehne JH; Sprenger KJ; Malison RT
    J Sleep Res; 2010 Mar; 19(1 Pt 2):157-64. PubMed ID: 19682231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of daytime administration of zolpidem versus triazolam on memory.
    Wesensten NJ; Balkin TJ; Belenky GL
    Eur J Clin Pharmacol; 1995; 48(2):115-22. PubMed ID: 7589024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the effects of zaleplon, zolpidem, and triazolam on memory, learning, and psychomotor performance.
    Troy SM; Lucki I; Unruh MA; Cevallos WH; Leister CA; Martin PT; Furlan PM; Mangano R
    J Clin Psychopharmacol; 2000 Jun; 20(3):328-37. PubMed ID: 10831020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zolpidem: distinct from triazolam?
    Lobo BL; Greene WL
    Ann Pharmacother; 1997 May; 31(5):625-32. PubMed ID: 9161660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute behavioral effects and abuse potential of trazodone, zolpidem and triazolam in humans.
    Rush CR; Baker RW; Wright K
    Psychopharmacology (Berl); 1999 Jun; 144(3):220-33. PubMed ID: 10435388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of chronic treatment with triazolam on operant responding in rats.
    Cohen C; Sanger DJ
    Pharmacol Biochem Behav; 1994 Nov; 49(3):455-61. PubMed ID: 7862694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicenter, double-blind, controlled comparison of zolpidem and triazolam in elderly patients with insomnia.
    Roger M; Attali P; Coquelin JP
    Clin Ther; 1993; 15(1):127-36. PubMed ID: 8458042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triazolam and zolpidem: effects on human memory and attentional processes.
    Mintzer MZ; Griffiths RR
    Psychopharmacology (Berl); 1999 May; 144(1):8-19. PubMed ID: 10379619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the daytime sleep and performance effects of zolpidem versus triazolam.
    Balkin TJ; O'Donnell VM; Wesensten N; McCann U; Belenky G
    Psychopharmacology (Berl); 1992; 107(1):83-8. PubMed ID: 1589566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flumazenil antagonizes the central effects of zolpidem, an imidazopyridine hypnotic.
    Patat A; Naef MM; van Gessel E; Forster A; Dubruc C; Rosenzweig P
    Clin Pharmacol Ther; 1994 Oct; 56(4):430-6. PubMed ID: 7955804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zolpidem and triazolam do not affect the nocturnal sleep-induced memory improvement.
    Meléndez J; Galli I; Boric K; Ortega A; Zuñiga L; Henríquez-Roldán CF; Cárdenas AM
    Psychopharmacology (Berl); 2005 Aug; 181(1):21-6. PubMed ID: 15830236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective antagonism of the ataxic effects of zolpidem and triazolam by the GABAA/alpha1-preferring antagonist beta-CCt in squirrel monkeys.
    Platt DM; Rowlett JK; Spealman RD; Cook J; Ma C
    Psychopharmacology (Berl); 2002 Nov; 164(2):151-9. PubMed ID: 12404077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sedative, memory, and performance effects of hypnotics.
    Roehrs T; Merlotti L; Zorick F; Roth T
    Psychopharmacology (Berl); 1994 Oct; 116(2):130-4. PubMed ID: 7862941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zolpidem and triazolam in humans: behavioral and subjective effects and abuse liability.
    Evans SM; Funderburk FR; Griffiths RR
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1246-55. PubMed ID: 2262904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zolpidem, triazolam, and diazepam decrease distress vocalizations in mouse pups: differential antagonism by flumazenil and beta-Carboline-3-carboxylate-t-butyl ester (beta-CCt).
    Rowlett JK; Tornatzky W; Cook JM; Ma C; Miczek KA
    J Pharmacol Exp Ther; 2001 Apr; 297(1):247-53. PubMed ID: 11259551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of zolpidem and triazolam on sleep and respiration in mild to moderate chronic obstructive pulmonary disease.
    Steens RD; Pouliot Z; Millar TW; Kryger MH; George CF
    Sleep; 1993 Jun; 16(4):318-26. PubMed ID: 8341892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects in humans after repeated administrations of zolpidem and triazolam.
    Stoops WW; Rush CR
    Am J Drug Alcohol Abuse; 2003 May; 29(2):281-99. PubMed ID: 12765207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temporal changes in postural sway caused by ultrashort-acting hypnotics: triazolam and zolpidem.
    Nakamura M; Ishii M; Niwa Y; Yamazaki M; Ito H
    ORL J Otorhinolaryngol Relat Spec; 2005; 67(2):106-12. PubMed ID: 15821354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zolpidem, triazolam, and temazepam: behavioral and subject-rated effects in normal volunteers.
    Rush CR; Griffiths RR
    J Clin Psychopharmacol; 1996 Apr; 16(2):146-57. PubMed ID: 8690830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.